Changes in receptivity epithelial cell markers of endometrium after ovarian stimulation treatments: its role during implantation window

Table 1 Summary of clinical data from patients included in all groups

	OP	UI	CC-treated	rFSH-treated
No. of patients (n)	12	10	12	10
Age (years)	30.83 ± 3.27	31.32 ± 3.58	31 ± 4.39	30.46 ± 3.95
Body mass index (kg/m²)	26.24 ± 2.70	26.48 ± 2.91	26.74 ± 2.80	25.98 ± 2.70
Basal hormonal profile
PRL (ng/mL)	17.46 ± 2.44	13.78 ± 2.32	15.93 ± 2.82	12.75 ± 3.11
E₂ (pg/mL)	35.13 ± 1.85	27.34 ± 3.12	46.61 ± 2.67	24.8 ± 2.28
LH (IU/L)	6.42 ± 1.16	4.98 ± 0.84	4.82 ± 1.07	5.80 ± 0.77
FSH (IU/L)	7.27 ± 0.94	8.86 ± 1.16	5.79 ± 0.79	6.07 ± 0.64
LH + 7 day hormonal profile
E₂ (pg/mL)	26 ± 2.04	31.05 ± 3.08	25.33 ± 2.16	48.51 ± 3.27
P₄ (ng/mL)	12.01 ± 1.54	7.19 ± 1.98	20.87 ± 4.32	6.97 ± 1.14
Histological dating (cycle day)	19 ± 0.42	19 ± 0.7	19 ± 0.44	17 ± 0.79

Clinical data from the ovulatory patients (OP), untreated infertile (UI), clomiphene citrate (CC) and recombinant follicle stimulating hormone (rFSH) treated patients. Data represents mean ± SE. Hormonal measurement at basal condition (day 3) and after treatments in LH + 7 day, as well as histological dating in all groups

ISSN: 1742-4755